Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This phase II trial studies whether the nonavalent human papillomavirus vaccine given to adults prior to kidney transplantation can help the body build and maintain an effective immune response during the post-transplant period when they receive immunosuppressive drugs to prevent transplant rejection. This study will help inform our scientific understanding about vaccine-induced immune responses among immunosuppressed individuals.
Epistemonikos ID: 62f4188b38cf35ed086691bddfac80a5d20f0c5b
First added on: May 20, 2024